X4 Pharmaceuticals, Inc - COM (XFOR)

Historical Portfolio Holders from Q1 2019 to Q1 2024

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	102 M	$141 M	+$8.94 M	404 K	286 K	$1.39	94
2023 Q4	96.1 M	$80.6 M	-$18.9 M	122 K	58.8 K	$0.84	88
2023 Q3	112 M	$122 M	-$3.79 M	179 K	106 K	$1.09	88
2023 Q2	113 M	$219 M	+$104 M	736 K	10.4 M	$1.94	95
2023 Q1	60 M	$52.2 M	+$698 K	125 K	43.3 K	$0.87	51
2022 Q4	60.6 M	$60.2 M	+$20.6 M	179 K	141 K	$0.99	49
2022 Q3	39.1 M	$66.8 M	+$39.5 M	176 K	44 K	$1.71	50
2022 Q2	16 M	$15.5 M	-$674 K	31 K	24 K	$0.97	41
2022 Q1	16.3 M	$28.6 M	-$2.24 M	220 K	37 K	$1.75	51
2021 Q4	17.6 M	$40.2 M	-$2.28 M	389 K	181 K	$2.29	49
2021 Q3	16.2 M	$85.7 M	-$2.79 M	60 K	393 K	$5.29	49
2021 Q2	16.3 M	$106 M	+$941 K		151 K	$6.50	58
2021 Q1	16.1 M	$139 M	+$48.9 M			$8.61	59
2020 Q4	9.74 M	$62.6 M	+$1.45 M			$6.43	50
2020 Q3	9.51 M	$64.4 M	-$4.9 M		0	$6.77	48
2020 Q2	10.7 M	$99.6 M	-$2.65 M		1.4 M	$9.32	52
2020 Q1	11.2 M	$112 M	+$1.38 M		1.5 M	$10.00	47
2019 Q4	11 M	$118 M	+$34.8 M		1.61 M	$10.70	51
2019 Q3	7.71 M	$98 M	+$1.6 M		636 K	$12.71	47
2019 Q2	7.58 M	$114 M	+$86.9 M		750 K	$15.00	42
2019 Q1	1.79 M	$31.1 M	+$31.1 M			$17.41	28